A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT). (2018)

First Author: Irvine AD

Attributed to: Cutaneous Immunology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjd.16717

PubMed Identifier: 29727479

Publication URI: http://europepmc.org/abstract/MED/29727479

Type: Journal Article/Review

Volume: 179

Parent Publication: The British journal of dermatology

Issue: 6

ISSN: 0007-0963